Clinical‐scale production of cGMP compliant CD3/CD19 cell‐depleted NK cells in the evolution of NK cell immunotherapy at a single institution
暂无分享,去创建一个
Jeffrey S. Miller | D. Sumstad | D. Kadidlo | D. McKenna | J. Curtsinger | Xianghua Luo | Shelly M Williams | Shelly M. Williams